Hennion & Walsh Asset Management, Inc.

Position in DGX — Quest Diagnostics Inc

CIK 1861642 Parsippany, NJ

Position in DGX

as of Jun 30, 2026 · filed Jul 8, 2026 Compact

Position Value

$1,634,558

+$19,683 QoQ

Shares Held

7,712

-6.4% QoQ

Ownership

0.007%

of shares outstanding

% of Portfolio

0.06%

of 13F equity value

Holder Rank

#28

of 132 holders

Holding Since

Sep 2021

16 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Jun 30, 2026

Hennion & Walsh Asset Management, Inc. holds $9,011,750 across 5 Diagnostics & Research names. DGX ranks #4 (18.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	TMO	Thermo Fisher Scientific Inc.	5,549	$2,782,046
2	FLGT	Fulgent Genetics, Inc.	111,405	$2,286,030
3	DHR	Danaher Corp /De/	9,837	$1,873,751
4	DGX	Quest Diagnostics Inc This page	7,712	$1,634,558
5	IDXX	Idexx Laboratories Inc /De	827	$435,365

16 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,634,558	7,712	-6.4%	Shares	Sole	2026-07-08
2026-03-31	$1,614,875	8,240	+13.1%	Shares	Sole	2026-05-13
2025-12-31	$1,263,818	7,283	+11.4%	Shares	Sole	2026-01-14
2025-09-30	$1,246,202	6,539	+63.4%	Shares	Sole	2025-10-22
2025-06-30	$718,699	4,001	+34.8%	Shares	Sole	2025-08-07
2025-03-31	$502,354	2,969	+91.9%	Shares	Sole	2025-04-10
2024-12-31	$233,380	1,547	+6.9%	Shares	Sole	2025-01-15
2024-09-30	$224,646	1,447	-57.6%	Shares	Sole	2024-10-22
2023-06-30	$479,169	3,409	-15.1%	Shares	Sole	2023-08-09
2023-03-31	$567,759	4,013	-8.7%	Shares	Sole	2023-04-20
2022-12-31	$687,866	4,397	-7.4%	Shares	Sole	2023-01-12
2022-09-30	$582,409	4,747	-4.8%	Shares	Sole	2022-11-14
2022-06-30	$663,038	4,986	-1.3%	Shares	Sole	2022-07-19
2022-03-31	$691,553	5,053	+3.9%	Shares	Sole	2022-04-26
2021-12-31	$841,520	4,864	+48.2%	Shares	Sole	2022-02-14
2021-09-30	$477,052	3,283	—	Shares	Sole	2021-11-12
No filing history on record for this holder in this stock.